Owkin shares promising validation results for BRCAura RUO, a clinical-grade research-use-only AI product designed to screen for germline BRCA1/2 mutations (gBRCAm) directly from digitized breast ...
Affinity Technologies, Inc. , a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today announced that Chief Medical Officer Gordon Downie, MD, PhD, will ...
The Supreme Champion heifer stole the spotlight, topping the trade and selling for an impressive £9,250 at the Clogher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback